SMTL ID : 7vjt.2 (1 other biounit)

Crystal Structure of Mtb Pks13-TE in complex with inhibitor coumestan derivative 8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.94 Å

Oligo State

monomer

Ligands

1 x 7IJ: 3,8-bis(oxidanyl)-7-(piperidin-1-ylmethyl)-[1]benzofuro[3,2-c]chromen-6-one(Non-covalent)

7IJ.1: 14 residues within 4Å: Chain A: R.136, F.143, Q.191, S.194, Y.195, N.198, R.199, I.201, D.202, Y.221, A.225, F.228, E.229, Y.232 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.195, A:N.198, A:R.199, A:I.201, A:Y.221, A:A.225, A:F.228, A:Y.232 Hydrogen bonds: A:Q.191, A:Q.191, A:D.202 Water bridges: A:S.194, A:R.199 Salt bridges: A:D.202 pi-Stacking: A:F.228, A:F.228

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, W. et al., Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment. J.Med.Chem. (2022)

Release Date

2022-09-28

Peptides

Polyketide synthase Pks13 (Termination polyketide synthase): A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Polyketide synthase Pks13 (Termination polyketide synthase)

Related Entries With Identical Sequence